You could be right sean. One deal that could really move things along would be the bundling of HCV and HBV. If the AAV vector proves 100% successful, then this is a possibility. One thing is for sure, we are only a short time away from finding out what the market really thinks.
Add to My Watchlist
What is My Watchlist?